Eli Lilly and Novo Nordisk are boosting supply of their weight loss drugs, while Apple Watch's heart monitoring tech was approved for use in clinical studies.
Amgen, Viking Therapeutics, Altimmune, AstraZeneca, Boehringer Ingelheim and Zealand Pharma are progressing on their own treatments.
The disgraced Theranos founder is on track to be released in August 2032, two years earlier than expected, after she was sentenced to more than 11 years for fraud.
Amgen's update fueled concerns about potential new competition in the weight loss drug market, sending shares of Novo Nordisk and Eli Lilly lower.
Amgen is among several drugmakers racing to join the red-hot weight loss drug space dominated by Novo Nordisk and Eli Lilly.
The company reiterated its full-year 2024 sales guidance of roughly $4 billion, which includes revenue from the expected launch of its RSV vaccine.
https://www.cnbc.com/2024/05/02/moderna-mrna-earnings-q1-2024.html
UnitedHealth CEO estimates that data from one-third of Americans could have been compromised in the Change Healthcare cyberattack.
Senators questioned UnitedHealth Group CEO Andrew Witty on Wednesday about a cyberattack on its subsidiary Change Healthcare.
https://www.cnbc.com/2024/05/01/unitedhealth-ceo-says-company-paid-hackers-22-million-ransom.html
AbbVie has two successors that could offset the losses from its blockbuster drug Humira. Meanwhile, UnitedHealth Group's CEO will testify on Capitol Hill.
The pharmaceutical giant's quarterly results also benefited from a smaller-than-feared drop in sales for its Covid antiviral pill Paxlovid.
https://www.cnbc.com/2024/05/01/pfizer-pfe-earnings-q1-2024.html
CVS and other insurers have seen medical costs spike as many Medicare Advantage patients return to hospitals to undergo procedures they delayed during Covid.
https://www.cnbc.com/2024/05/01/cvs-health-cvs-earnings-q1-2024.html
The deal would allow J&J to resolve the lawsuits through a third bankruptcy filing of a subsidiary company, LTL Management.
Many doctors have been left without a way to get paid for their services.
Every weekday, the Investing Club releases the Homestretch; an actionable afternoon update just in time for the last hour of trading.
The world's most valuable drugmaker hiked its full-year sales and profit guidance, despite missing lighter-than-expected first-quarter revenue.
The agency sent letters to Novo Nordisk, AstraZeneca, Boehringer Ingelheim, Covis Pharma, GlaxoSmithKline, Novartis, Teva Pharmaceuticals, among others.
https://www.cnbc.com/2024/04/30/ftc-challenges-patents-held-by-drugmakers-including-for-ozempic.html
Walmart said clinics are not a sustainable business model due to a challenging reimbursement environment for primary care and increasing operating costs.
https://www.cnbc.com/2024/04/30/walmart-to-shutter-health-centers-virtual-care-service.html
Zepbound reported $517.4 million in sales for the quarter, even as most doses of the drug slipped into shortages in the U.S.
https://www.cnbc.com/2024/04/30/eli-lilly-lly-earnings-q1-2024.html
The decision is another win for the Biden administration in a bitter legal fight with several drugmakers over the constitutionality of the price talks.
The Food and Drug Administration said supplies of Zepbound and Mounjaro are expected to be limited through the second quarter, for all but one dosage.
The delay comes two years after the Food and Drug Administration first announced its proposed rules for the ban.
https://www.cnbc.com/2024/04/26/biden-administration-delays-plans-to-ban-menthol-cigarettes.html
Dozens of pharmacy staff at the Las Vegas branch of CVS's Omnicare will now join the Pharmacy Guild, which will represent them in labor negotiations with CVS.
The agency greenlighted the drug, which will be marketed as Beqvez, for adults with moderate to severe hemophilia B.
Bristol Myers Squibb said the charges primarily reflect its acquisition of Karuna Therapeutics and collaboration agreement with SystImmune.
https://www.cnbc.com/2024/04/25/bristol-myers-squibb-bmy-earnings-q1-2024.html
The first-quarter results come as Merck shows substantial progress in preparing for Keytruda's patent expiration in 2028.
https://www.cnbc.com/2024/04/25/merck-mrk-earnings-q1-2024.html
Among the company's investments to "transform" its specialty pharmacy services is the opening of a new facility dedicated to cell and gene therapy services.
https://www.cnbc.com/2024/04/25/walgreens-launches-cell-gene-therapies-in-service-expansion.html
Before insurance, Novo Nordisk charges about $1,000 per month for Ozempic in the United States. In Germany, the company charges $59 per month for the same drug.
Wells Fargo believes the company's hyperplasia and depression treatments could each become over $1 billion opportunities.
https://www.cnbc.com/2024/04/24/wells-fargo-becomes-bullish-on-this-biotech-company.html
Alzheimer's drug Leqembi brought in approximately $19 million in sales for the quarter, up from the $10 million the drug generated last year.
https://www.cnbc.com/2024/04/24/biogen-biib-earnings-q1-2024-.html
For the first time, some Medicare beneficiaries will be able to access Novo Nordisk's Wegovy without having to shoulder the total monthly price tag.